Інститут гормонального балансу представляє препарат EXOMIND від депресії

The Institute for Hormonal Balance in Arlington, Texas, has launched a new non-invasive treatment for people experiencing depression, anxiety, and mental fog. The treatment, called EXOMIND, uses brain stimulation technology to improve mental health without the need for medication.

Mandy Cotten, a Family Nurse Practitioner and owner of the Institute, emphasizes the importance of non-invasive tools in today’s stress-filled environment. “EXOMIND is an FDA-cleared treatment that aligns with our dedication to providing high-quality patient care,” she said.

EXOMIND employs magnetic pulses to stimulate or inhibit specific brain activity. This approach targets areas of the brain that are crucial for emotional regulation and cognitive function. Patients typically undergo treatment twice a week for three weeks to achieve optimal results.

Research indicates that 100% of patients undergoing EXOMIND reported a reduction in food cravings, and many experienced an average weight loss of four to five pounds after six sessions. This could be particularly beneficial for those looking to manage their weight alongside their mental health.

In addition to EXOMIND, the Institute offers several advanced technologies aimed at enhancing overall health. The Emsculpt NEO device helps burn up to 30% of fat and build up to 25% of muscle in targeted areas, including the abdomen and thighs. Emface is recognized as the first FDA-cleared device that tightens facial muscles while lifting loose skin on the cheeks and jawline. For individuals dealing with incontinence, the EMSELLA chair provides a non-invasive solution through muscle activation, achieving a 98% patient satisfaction rate in restoring bladder function.

To celebrate Mental Health Awareness Month, the Institute is hosting an EXOMIND & Motion launch party on May 30, from 3 to 5 p.m. at their facility located at 4224 Park Springs, Ste. 100, Arlington, Texas 76016. Attendees can learn more about the EXOMIND treatment and experience demonstrations of other technologies. The event will also feature refreshments, raffle prizes, and special pricing for participants. To RSVP, individuals can contact 817-467-7474 or visit the Institute’s website.

This initiative marks a significant advancement in the options available for treating mental health conditions, offering patients a new avenue for improving their wellbeing without the reliance on traditional medication.